Research Article

Molecular Confirmation of Vancomycin-Resistant Staphylococcus aureus with vanA Gene from a Hospital in Kathmandu

Table 1

Distribution of MRSA and VRSA isolates.

Organism/distributionGrowth positive, n (%)Gram positive, n (%)S. aureus, n (%)MRSA, n (%)VRSA, n (%)

Sex
 Male (n = 409)215 (52.6)93 (43.2)42 (19.5)29 (69.0)3 (10.3)
 Female (n = 386)149 (38.6)61 (40.9)32 (21.5)16 (50.0)2 (12.5)
Clinical samples
 Urine (n = 279)135 (48.3)32 (23.7)10 (7.4)3 (50.0)0
 Sputum (n = 126)61 (48.4)29 (47.5)13 (21.3)5 (38.5)0
 Blood (n = 118)20 (16.9)7 (35.0)6 (30.0)2 (33.3)0
 Pus (n = 109)54 (49.5)34 (62.9)16 (29.6)14 (87.5)3 (21.4)
 Wound swab (n = 92)57 (61.9)42 (73.7)27 (47.4)21 (77.8)2 (9.5)
Others (n = 71)17 (23.9)10 (58.8)2 (11.8)00
Hospital units
 General ward (n = 370)160 (43.2)66 (41.3)32 (20.0)20 (62.5)2 (10.0)
 OPD (n = 171)91 (53.2)35 (38.5)15 (16.5)9 (60.0)1 (11.1)
 ICU (n = 125)65 (52.0)31 (47.6)17 (26.2)12 (70.5)2 (16.7)
 Gynae (n = 129)48 (37.2)22 (45.8)10 (20.8)4 (40.0)0
Total (n=795)364 (45.8)154 (42.3)74 (20.3)45 (60.8)5 (11.1)

Abbreviations: MRSA = methicillin-resistant Staphylococcus aureus; VRSA = vancomycin-resistant Staphylococcus aureus; others = throat swab, vaginal swab, synovial fluid, and pleural fluid; percentage calculated on respective row total.